SALT FORMS OF ORGANIC COMPOUND

摘要

The present invention relates to novel salt forms of 1- [ (4 -methyl -quinazolin- 2 -yl) methyl] -3-methyl-7- (2 -butyn-1-yl) -8- (3- (R) -amino- piperidin-1-yl) -xanthine, a DPP- 4 inhibitor and their use in pharmaceutical compositions useful in the treatment of type 2, diabetes, as well as their production.